Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Product Lead - Biologics Discovery Platform

At AstraZeneca, we aim to revolutionise antibody discovery by significantly reducing the time to reach a clinical candidate using world-class technology and advanced data & AI capabilities. The Biologics Discovery Platform Product Lead will build a multi-quarter product roadmap and strategy to deliver an excellent science user experience, partnering with R&D product owners and cross-functional teams that  work in the earliest stages of Biologics discovery.

Contract Manager

About Maxion

Maxion Therapeutics is a pioneering biotechnology company dedicated to developing groundbreaking biologic medicines for diseases with unmet needs, driven by ion channel and GPCR dysfunction. Our innovative KnotBody® technology empowers us to create potent, selective, and durable antibody therapeutics. This technology merges millions of years of cysteine-rich mini-protein ('Knottin') evolution with cutting-edge antibody engineering, addressing pivotal challenges in ion channel/GPCR drug discovery.

Insights Senior Analyst, Global Health & Diagnostics

The Insights team is LifeArc’s central resource for analysing scientific, competitive and IP landscapes to support strategy, project selection and portfolio decisions. The team works closely with LifeArc Ventures and our Translational Challenges to analyse the potential of translational life science opportunities, informing decision making and ensuring LifeArc achieves maximum patient impact.

Accelerate@Babraham Applications Now Open!

Starting something new is hard – particularly within the fast-moving life science sector. Step forward Accelerate@Babraham, the Babraham Research Campus’ bio-incubator, founded out of a desire to support and nurture early-stage ventures; bringing to bear an unrivalled network of experts, mentors and investors and data-driven, comprehensive business analysis and support to equip these young enterprises with the skills, confidence and network connections to enable success.

Portfolio Manager, Custom Services

bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

Coulter Partners places industrial biotech leader Thomas Durhuus as CEO of Kaffe Bueno

LONDON, UK and COPENHAGEN, Denmark  – February 2, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Kaffe Bueno and is pleased to announce the placement of Thomas Durhuus as Chief Executive Officer (CEO).

The Pre-Notification Trap: How Life Science, Biotech and Med-Tech Companies Are Losing R&D Tax Credits

R&D Tax Credit Pre-Notification: A Critical Requirement for Innovators

Pre-notification is now a mandatory legislative requirement for certain companies intending to claim R&D tax credits. Introduced as part of HMRC’s reforms to the R&D tax relief regime, the rule applies to companies that are first-time claimants or those that have not made a relevant R&D tax credit claim in the previous three accounting periods. Affected companies must notify HMRC of their intention to claim within six months of the end of the relevant accounting period.

Senior Research Scientist microbiome assay and metaproteomics

The Quadram Institute is a cutting-edge £75 million facility with strategic research programmes in Food, Microbiome and Health, and Microbes and Food Safety.  We bring together a diverse team of researchers, academics, and NHS clinicians to tackle pressing issues in human health, food, and disease. Our innovative approach bridges food science, gut biology, and human health, leveraging the world-class bioscience cluster at Norwich Research Park.

The role

Subscribe to